Clinical performance of the iPREDICTLIVING tool for the prediction of the post‐transplant recipient and living donor outcomes in a European cohort
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Manuela Almeida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal. Hauptthemen laut MEDLINE: Living Donors, Kidney Transplantation. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
A living donor kidney transplant (LDKT) is the best treatment for ESRD. A prediction tool based on clinical and demographic data available pre‐KT was developed in a Norwegian cohort with three different models to predict graft loss, recipient death, and donor candidate's risk of death, the iPREDICTLIVING tool. No external validations are yet available. We sought to evaluate its predictive performance in our cohort of 352 pairs LKDT submitted to KT from 1998 to 2019. The model for censored graft failure (CGF) showed the worse discriminative performance with Harrell's C of .665 and a time‐dependent AUC of .566, with a calibration slope of .998. For recipient death, at 10 years, the model had a Harrell's C of .776, a time‐dependent AUC of .773, and a calibration slope of 1.003. The models for donor death were reasonably discriminative, although with a poor calibration, particularly for 20 years of death, with a Harrell's C of .712 and AUC of .694 with a calibration slope of .955. These models have moderate discriminative and calibration performance in our population. The tool was validated in this Northern Portuguese cohort, Caucasian, with a low incidence of diabetes and other comorbidities. It can improve the informed decision‐making process at the living donor consultation joining clinical and other relevant information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.
- UMIB - Unit for Multidisciplinary Research in Biomedicine, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
- ITR - Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.
- Instituto Portugês do Sangue e Transplantação, Porto, Portugal.
- Department of Urology, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.
ORCID-Profile: Manuela Almeida, Jorge Malheiro
Förderung
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Almeida, M., Ribeiro, C., Silvano, J., Pedroso, S., Tafulo, S., Martins, S., Ramos, M., & Malheiro, J. (2024). Clinical performance of the iPREDICTLIVING tool for the prediction of the post‐transplant recipient and living donor outcomes in a European cohort. Clinical Transplantation. https://doi.org/10.1111/ctr.15283
Vancouver
Almeida M, Ribeiro C, Silvano J, Pedroso S, Tafulo S, Martins S, et al. Clinical performance of the iPREDICTLIVING tool for the prediction of the post‐transplant recipient and living donor outcomes in a European cohort. Clinical Transplantation. 2024. doi:10.1111/ctr.15283
BibTeX
@article{Almeida2024,
author = {Almeida, Manuela and Ribeiro, Catarina and Silvano, José and Pedroso, Sofia and Tafulo, Sandra and Martins, La Salete and Ramos, Miguel and Malheiro, Jorge},
title = {Clinical performance of the iPREDICTLIVING tool for the prediction of the post‐transplant recipient and living donor outcomes in a European cohort},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15283}
}
EUVIMED